1. EP-1372 External Validation of a Survival Score for Limited Disease Small Cell Lung Cancer (LD-SCLC). (April 2019) Authors: Käsmann, L.; Abdo, R.; Eze, C.; Dantes, M.; Taugner, J.; Gennen, K.; Roengvoraphoj, O.; Rades, D.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1374 ECOG-PS and its changes in inoperable stage III NSCLC patients treated with chemoradiotherapy. (April 2019) Authors: Käsmann, L.; Taugner, J.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Gennen, K.; Karin, M.; Tufman, A.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1375 Heterogeneity score in inoperable stage III NSCLC patients treated with definitive chemoradiotherapy. (April 2019) Authors: Taugner, J.; Käsmann, L.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Gennen, K.; Karin, M.; Tufman, A.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0780 Prognostic value of PD-L1 expression in locally advanced NSCLC treated with chemoradiotherapy. (April 2019) Authors: Gennen, K.; Käsmann, L.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Taugner, J.; Neumann, J.; Mille, E.; Tufman, A.; Huber, R.M.; Orth, M.; Reu, S.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-0997: Evaluation of outcome and toxicity of Durvalumab treatment after CRT in inoperable stage III NSCLC. (November 2020) Authors: Käsmann, L.; Taugner, J.; Eze, C.; Roengvoraphoj, O.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0998: Durvalumab treatment after CRT in inoperable stage III NSCLC – a German radiation oncology survey. (November 2020) Authors: Käsmann, L.; Taugner, J.; Eze, C.; Roengvoraphoj, O.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-0999: Deciphering the tumor microenviroment based on PD-L1 expression and CD8 + TILs density in LA-NSCLC. (November 2020) Authors: Käsmann, L.; Gennen, K.; Taugner, J.; Eze, C.; Karin, M.; Roengvoraphoj, O.; Neumann, J.; Tufman, A.; Orth, M.; Reu, S.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-1029: Preliminary analysis of patient cohorts treated pre vs post approval of consolidation IO in LANSCLC. (November 2020) Authors: Taugner, J.; Käsmann, L.; Eze, C.; Roengvoraphoj, O.; Tufman, A.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-1031: Initial report on feasibility of Hypo-IGRT in stage IIB-III NSCLC pts with poor PS & lung function. (November 2020) Authors: Eze, C.; Taugner, J.; Schmidt-Hegemann, N.; Roengvoraphoj, O.; Käsmann, L.; Dantes, M.; Li, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-1159 Prognostic role of pro-inflammatory cytokines in multimodal treatment of inoperable stage III NSCLC. (August 2021) Authors: Käsmann, L.; Cabeza-Boeddinghaus, N.; Taugner, J.; Eze, C.; Flörsch, B.; Hofer, T.; Pelikan, C.; Belka, C.; Noessner, E.; Staab-Weijnitz, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S962 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗